Adema, Aaltje Y.
,
de Roij van Zuijdewijn, Camiel L. M.
Hoenderop, Joost G.
de Borst, Martin H.
Ter Wee, Piet M.
Heijboer, Annemieke C.
Vervloet, Marc G.
Funding for this research was provided by:
Nierstichting (CP10.11)
Article History
Received: 6 November 2017
Accepted: 22 October 2018
First Online: 15 November 2018
Ethics approval and consent to participate
: The study was conducted according to the principles of the Declaration of Helsinki and in accordance with the Medical Research Involving Human Subjects Act (WMO, The Netherlands). All participants provided written informed consent. The study was approved by the local Medical Ethics Committee of VU University Medical Center (METC 214.224, EudraCT 2013–003354-24).
: Not applicable.
: A.Y. Adema: NoneC.L.M. de Roij van Zuijdewijn: NoneJ.G. Hoenderop: NoneM.H. de Borst: NoneP.M. ter Wee: NoneA.C. Heijboer: NoneM.G. Vervloet: received financial support for research, consultancy of lecture fees from Vifor, Fresenius Medical Care Renal Pharma, Amgen, Medice, Baxter, Shire and Otsuka.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.